Upgrade to SI Premium - Free Trial

AstraZeneca (AZN) PT Raised to $220 at Leerink Partners

March 27, 2026 4:33 PM
Leerink Partners analyst Andrew Berens raised the price target on AstraZeneca (NASDAQ: AZN) to $220.00 (from $219.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change